Recombinant Therapeutic Antibodies and Proteins are produced by combining DNA proteins with bacterial cells for pharmaceutical applications

Among the many concerns that have been raised against the use of Recombinant Therapeutic Antibodies and Proteins, and other recombinant proteins for treating non-infectious diseases, are the dangers of hormonal therapy, which can cause severe adverse effects in humans. The dangers of allergic reactions to therapeutic proteins were also raised, citing the possibility of causing rashes, nausea, vomiting, and other gastrointestinal disturbances in patients. These reactions are in addition to the usual risks that occur when viruses or allergens are introduced into the body. Allergies caused by foreign proteins that have not been thoroughly checked and evaluated prior to use are considered allergenic reactions.

Most health care providers and physicians claim that the most common reactions caused by these products are an allergic reaction, gastrointestinal disturbances and rashes. The incidence of allergic reactions may vary, based on individual immunity and exposure to allergens. Rashes and hives are considered to be signs of allergies when they occur in conjunction with red bumps resembling a skin rash. According to medical experts, hives that occur due to the use of these products are considered to be a type of allergic reaction caused by the action of some of the chemical components of these coagulation factors. It should be noted that although the use of Recombinant Therapeutic Antibodies and Proteins has reduced the incidence of allergic reactions, it is still important that precautionary measures are taken to avoid any possible allergic reaction.